Home - Products - Angiogenesis - EGFR - WHI-P154

WHI-P154

CAS No. 211555-04-3

WHI-P154( JAK3 Inhibitor II | Janus-Associated Kinase 3 Inhibitor II )

Catalog No. M13364 CAS No. 211555-04-3

WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	32	In Stock
5MG	50	In Stock
10MG	79	In Stock
25MG	167	In Stock
50MG	314	In Stock
100MG	510	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

WHI-P154
Note

Research use only, not for human use.
Brief Description

WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.
Description

WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.
In Vitro

——
In Vivo

——
Synonyms

JAK3 Inhibitor II | Janus-Associated Kinase 3 Inhibitor II
Pathway

Angiogenesis
Target

EGFR
Recptor

EGFR| JAK3| Src| VEGFR
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

211555-04-3
Formula Weight

376.2
Molecular Formula

C16H14BrN3O3
Purity

>98% (HPLC)
Solubility

DMSO: 75 mg/mL (199.36 mM)
SMILES

OC1=CC=C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)C=C1Br
Chemical Name

2-Bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenol

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.O'Donoghue ML, et al. J Thromb Thrombolysis. 2012 Jul;34(1):36-43.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Cavutilide

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
AG-825

AG-825（Tyrphostin C15） is a selective and competitive ErbB2 inhibitor that inhibits tyrosine phosphorylation with an IC50 value of 0.35 μM.AG-825 (Tyrphostin C15) inhibits HER2 and shows anticancer activity in a mouse xenograft model of breast cancer.
Poziotinib hydrochlo...

Poziotinib hydrochloride irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors.?It is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity.?

Sign In Join Free